Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCapWealth Advisors, LLC
Latest Disclosed Ownership235,217 shares
Latest Disclosed Value $ 32,782,165
CapWealth Advisors, LLC reports 3.84% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 5, 2026 - CapWealth Advisors, LLC filed a 13F-HR form disclosing ownership of 235,217 shares of Gilead Sciences, Inc. (CH:GILD) valued at $32,782,165 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 6, 2026 disclosing 244,611 shares of Gilead Sciences, Inc.. This represents a change in shares of -3.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 235,217 -9,394 -3.84 32,782 9.19 2.4334
2026-02-06 2025-12-31 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 244,611 1,004 0.41 30,024 11.03 2.0548
2026-02-02 2025-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 244,611 1,004 30,024 2.0408
2026-02-06 2025-09-30 13F/A-2 GILEAD SCIENCES INC COM Stock 375558103 243,607 -9,320 -3.68 27,040 -3.57 1.8618
2025-10-30 2025-09-30 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 243,607 -9,320 27,040 1.8481
2025-10-21 2025-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 243,607 -9,320 27,040 2.4379
2025-07-29 2025-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 252,927 -1,317 -0.52 28,042 -1.57 2.7607
2025-04-30 2025-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 254,244 529 0.21 28,488 21.56 3.0845
2025-01-30 2024-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 253,715 -4,276 -1.66 23,436 8.35 2.5689
2024-10-31 2024-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 257,991 349 0.14 21,630 22.36 2.3523
2024-08-05 2024-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 257,642 -10,396 -3.88 17,677 -9.97 2.2330
2024-05-03 2024-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 268,038 4,947 1.88 19,634 -7.88 2.2038
2024-01-31 2023-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 263,091 -7,374 -2.73 21,313 5.15 2.5995
2023-11-01 2023-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 270,465 -5,363 -1.94 20,269 -4.66 2.6010
2023-08-07 2023-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 275,828 -3,852 -1.38 21,258 -8.39 2.5930
2023-05-02 2023-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 279,680 -4,255 -1.50 23,205 -4.80 2.8946
2023-02-01 2022-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 283,935 -841 -0.30 24,376 38.75 2.8648
2022-11-02 2022-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 284,776 3,784 1.35 17,568 1.15 2.3183
2022-08-05 2022-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 280,992 9,294 3.42 17,368 7.53 2.0947
2022-05-04 2022-03-31 13F/A-2 GILEAD SCIENCES INC COM Stock 375558103 271,698 -3,852 -1.40 16,152 -19.27 1.6535
2022-05-03 2022-03-31 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 272,098 -3,452 16,176 1.5646
2022-05-02 2022-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 272,098 -3,452 16,176 1.7228
2022-02-10 2021-12-31 13F GILEAD SCIENCES INC COM COM 375558103 275,550 2,786 1.02 20,008 5.01 2.0358
2021-11-09 2021-09-30 13F GILEAD SCIENCES INC COM COM 375558103 272,764 619 0.23 19,053 1.67 2.0871
2021-08-10 2021-06-30 13F GILEAD SCIENCES INC COM COM 375558103 272,145 38,969 16.71 18,740 24.35 2.0341
2021-05-03 2021-03-31 13F GILEAD SCIENCES INC COM COM 375558103 233,176 21,161 9.98 15,070 22.00 1.7149
2021-02-17 2020-12-31 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 212,015 60,938 40.34 12,352 29.38 1.4721
2021-02-02 2020-12-31 13F GILEAD SCIENCES INC COM COM 375558103 212,015 60,938 12,352 1,492,930.5773
2020-11-12 2020-09-30 13F GILEAD SCIENCES INC COM COM 375558103 151,077 2,233 1.50 9,547 -16.63 1.2751
2020-08-12 2020-06-30 13F GILEAD SCIENCES INC COM COM 375558103 148,844 11,608 8.46 11,452 11.62 1.6185
2020-05-08 2020-03-31 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 137,236 137,236 10,260 1.8360
2020-05-08 2020-03-31 13F GILEAD SCIENCES COM 375558103 11,359 11,359 767 109,670.9158
2019-10-29 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -11,359 -100.00 0 -100.00
2019-08-13 2019-06-30 13F GILEAD SCIENCES COM 375558103 11,359 -70,811 -86.18 767 -85.64 0.1097
2019-05-15 2019-03-31 13F GILEAD SCIENCES INC COM COM 375558103 82,170 -9,073 -9.94 5,342 -6.40 0.8192
2019-02-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 91,243 -36,321 -28.47 5,707 -42.06 1.0029
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 127,564 1,521 1.21 9,849 10.30 1.6163
2018-08-15 2018-06-30 13F GILEAD SCIENCES COM 375558103 126,043 -20,423 -13.94 8,929 -19.14 1.5994
2018-05-14 2018-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 146,466 -4,746 -3.14 11,042 1.93 2.1352
2018-05-11 2018-03-31 13F GILEAD SCIENCES COM 375558103 151,212 0 10,833
2018-02-15 2017-12-31 13F GILEAD SCIENCES COM 375558103 151,212 1,721 1.15 10,833 -10.56 1.9496
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 149,491 29 0.02 12,112 14.49 2.3263
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 149,462 3,543 2.43 10,579 6.74 2.1207
2017-05-12 2017-03-31 13F GILEAD SCIENCES COM 375558103 145,919 8,189 5.95 9,911 0.49 2.0292
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 137,730 -10,089 -6.83 9,863 -15.66 2.1339
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 147,819 34,718 30.70 11,695 23.95 2.8114
2016-08-03 2016-06-30 13F GILEAD SCIENCES COM 375558103 113,101 3,066 2.79 9,435 -6.66 2.3056
2016-05-11 2016-03-31 13F GILEAD SCIENCES COM 375558103 110,035 2,526 2.35 10,108 -7.09 2.5712
2016-02-11 2015-12-31 13F GILEAD SCIENCES COM 375558103 107,509 -535 -0.50 10,879 2.55 2.6346
2015-11-12 2015-09-30 13F GILEAD SCIENCES COM 375558103 108,044 7,671 7.64 10,609 -9.73 2.6571
2015-08-14 2015-06-30 13F GILEAD SCIENCES COM 375558103 100,373 3,810 3.95 11,752 24.02 2.7705
2015-05-12 2015-03-31 13F GILEAD SCIENCES COM 375558103 96,563 4,400 4.77 9,476 9.08 2.2276
2015-02-11 2014-12-31 13F GILEAD SCIENCES COM 375558103 92,163 -8,527 -8.47 8,687 -18.95 2.0392
2014-11-12 2014-09-30 13F GILEAD SCIENCES COM 375558103 100,690 4,982 5.21 10,718 35.07 2.4329
2014-08-08 2014-06-30 13F GILEAD SCIENCES COM 375558103 95,708 11,730 13.97 7,935 33.34 1.8176
2014-05-12 2014-03-31 13F GILEAD SCIENCES COM 375558103 83,978 11,668 16.14 5,951 9.59 1.6010
2014-02-13 2013-12-31 13F GILEAD SCIENCES COM 375558103 72,310 22,110 44.04 5,430 72.05 1.3695
2013-11-13 2013-09-30 13F GILEAD SCIENCES COM 375558103 50,200 7,275 16.95 3,156 43.39 0.8784
2013-07-26 2013-06-30 13F GILEAD SCIENCES COM 375558103 42,925 42,925 2,201 0.6427
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.